发明名称 COMBINED USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
摘要 PROBLEM TO BE SOLVED: To provide a therapeutic method for acute myeloid leukemia.SOLUTION: The invention provides a therapeutic method for acute myeloid leukemia comprising intravenously administering arabinocytidine (4-amino 1-β-D-arabinofuranosyl 2(1H)-pyrimidinone) in combination with (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid represented by the following formula.SELECTED DRAWING: None
申请公布号 JP2016053070(A) 申请公布日期 2016.04.14
申请号 JP20150219880 申请日期 2015.11.09
申请人 SUNESIS PHARMACEUTICALS INC 发明人 ADELMAN DANIEL C;SILVERMAN JEFFREY A;MICHELSON GLENN;SCATENA CAROLINE DARNE
分类号 A61K31/4375;A61K31/7068;A61P35/02;A61P43/00 主分类号 A61K31/4375
代理机构 代理人
主权项
地址